Cell Harvesting Market - By Type: Automated Cell Harvesting Systems, Manual/Traditional Harvesting Systems; By Application: Biopharmaceutical Production, Stem Cell Research & Therapy, Cancer Immunotherapy, Regenerative Medicine; By End User: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinical Laboratories, Contract Development & Manufacturing Organizations (CDMOs); By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global cell harvesting market is expanding rapidly, fueled by the growing fields of regenerative medicine, stem cell therapies, cancer immunotherapy, and biopharmaceutical manufacturing. Cell harvesting remains a vital step in upstream bioprocessing, allowing the isolation of viable cells from culture systems for subsequent therapy development, research, and diagnostics.
Advancements in automated harvesting systems, single-use technologies, and closed-loop processing are enhancing efficiency and scalability. Growth is further driven by the increasing number of clinical trials in cell-based therapies, along with expanding applications in regenerative medicine, CAR-T cell manufacturing, and vaccine development.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
3.28 |
Historical benchmark |
|
2024 |
5.21 |
Five-year CAGR 9.7% |
|
2031 |
11.68 |
Seven-year CAGR 12.1% |
The market is expected to more than double by 2031, driven by rising demand for high-quality cell processing in research, clinical, and manufacturing environments.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The cell harvesting market is somewhat consolidated, with major players providing comprehensive solutions for research and clinical manufacturing.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Thermo Fisher Scientific |
21% |
CTS™ Rotea™, Dynabeads™ cell isolation systems |
|
Danaher (Cytiva) |
18% |
XDR™, Sepax™ cell processing systems |
|
Merck KGaA (MilliporeSigma) |
14% |
Mobius® cell harvesting solutions |
|
Sartorius AG |
11% |
Flexsafe® and BIOSTAT® systems |
|
Others (Eppendorf, Miltenyi Biotec, Terumo BCT, regional OEMs) |
36% |
Specialized harvesting and isolation equipment |
6 | Market Segmentation
By Type:
By Application:
By End User:
By Region:
7 | Strategic Outlook
The future of the cell harvesting market will emphasize closed-system automation, AI-powered process monitoring, and GMP-compliant scalable platforms. Growth will be fueled by the expansion of cell-based therapies, decentralized manufacturing models, and the increasing demand for flexible, contamination-free bioprocess solutions.
Need help?
Chat with our team in a minute.